Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “Vertex Pharmaceuticals Incorporated”

980 pharma patents match "Vertex Pharmaceuticals Incorporated" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 980
Index total 30,257
Page 29 / 41

Quick answer

This filtered view shows 980 pharmaceutical patents matching "Vertex Pharmaceuticals Incorporated" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

980 results for “Vertex Pharmaceuticals Incorporated” · 30,257 patents in full index Clear search

  1. US 7855220

    Bicyclic derivatives as modulators of voltage gated ion channels

    Vertex Pharmaceuticals Incorporated · Granted Dec 21, 2010 · Expires Dec 16, 2030

    granted
  2. US 7855214

    Fused cyclic systems useful as inhibitors of TEC family protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Dec 21, 2010 · Expires Dec 16, 2030

    granted
  3. US 7851495

    Thiophene-carboxamides useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Dec 14, 2010 · Expires Dec 9, 2030

    granted
  4. US 7846954

    Heterocyclic derivatives as modulators of ion channels

    Vertex Pharmaceuticals Incorporated · Granted Dec 7, 2010 · Expires Dec 2, 2030

    granted
  5. US 7846951

    Thiazoles and oxazoles useful as modulators of ATP-binding cassette transporters

    Vertex Pharmaceuticals Incorporated · Granted Dec 7, 2010 · Expires Dec 2, 2030

    granted
  6. US 7842686

    CGRP receptor antagonists

    Vertex Pharmaceuticals Incorporated · Granted Nov 30, 2010 · Expires Nov 25, 2030

    granted
  7. US 7842819

    Derivatives for modulation of ion channels

    Vertex Pharmaceuticals Incorporated · Granted Nov 30, 2010 · Expires Nov 25, 2030

    granted
  8. US 7838517

    Compounds useful as protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Nov 23, 2010 · Expires Nov 18, 2030

    granted
  9. US 7834200

    Processes and intermediates

    Vertex Pharmaceuticals Incorporated · Granted Nov 16, 2010 · Expires Nov 11, 2030

    granted
  10. US 7834000

    CGRP receptor antagonists

    Vertex Pharmaceuticals Incorporated · Granted Nov 16, 2010 · Expires Nov 11, 2030

    granted
  11. US 7829561

    Caspase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Nov 9, 2010 · Expires Nov 4, 2030

    granted
  12. US 7829723

    Polymorphic forms of (S)-1-cyanobutan-2-yl (S)-1-(3-3-(3-methoxy-4-(oxazol-5-yl)phenyl)uriedo)phenyl)ethylcarbamate

    Vertex Pharmaceuticals Incorporated · Granted Nov 9, 2010 · Expires Nov 4, 2030

    granted
  13. US 7825136

    Potentiators of antibacterial activity

    Vertex Pharmaceuticals Incorporated · Granted Nov 2, 2010 · Expires Oct 28, 2030

    granted
  14. US 7820685

    Aminopyrimidines useful as kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Oct 26, 2010 · Expires Oct 21, 2030

    granted
  15. US 7820817

    Modulators of muscarinic receptors

    Vertex Pharmaceuticals Incorporated · Granted Oct 26, 2010 · Expires Oct 21, 2030

    granted
  16. US 7820671

    Peptidomimetic protease inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Oct 26, 2010 · Expires Oct 21, 2030

    granted
  17. US 7816529

    Pyrimidines useful as modulators of voltage-gated ion channels

    Vertex Pharmaceuticals Incorporated · Granted Oct 19, 2010 · Expires Oct 14, 2030

    granted
  18. US 7807659

    Caspase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Oct 5, 2010 · Expires Sep 30, 2030

    granted
  19. US 7799822

    Phenyl sulfonamides as modulators of ion channels

    Vertex Pharmaceuticals Incorporated · Granted Sep 21, 2010 · Expires Sep 16, 2030

    granted
  20. US 7795259

    Pyrrolopyrazines and pyrazolopyrazines useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Sep 14, 2010 · Expires Sep 9, 2030

    granted
  21. US 7790713

    Inhibitors of interleukin-1β converting enzyme

    Vertex Pharmaceuticals Incorporated · Granted Sep 7, 2010 · Expires Sep 2, 2030

    granted
  22. US 7786137

    Bicyclic derivatives as modulators of ion channels

    Vertex Pharmaceuticals Incorporated · Granted Aug 31, 2010 · Expires Aug 26, 2030

    granted
  23. US 7786120

    Pyridones useful as inhibitors of kinases

    Vertex Pharmaceuticals Incorporated · Granted Aug 31, 2010 · Expires Aug 26, 2030

    granted
  24. US 7786308

    Muscarinic modulators

    Vertex Pharmaceuticals Incorporated · Granted Aug 31, 2010 · Expires Aug 26, 2030

    granted